MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-16-2026
T2 Biosystems ROCE Ratio 2011-2026 | TTOO
Annual ROCE Ratio T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177.14 | 139.19 | 333.05 | -59.7 | 162.25 | -113.17 | -1749.01 | -63.85 | -58.1 | -41.48 | -70.74 | -157.53 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 333.05 | -1749.01 | -125.16 |
Quarterly ROCE Ratio T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 353.21 | 302.27 | 167.36 | 134.01 | 183.9 | 153.19 | 175.28 | 147.84 | 643.66 | 474.11 | 2148.21 | 2090.29 | 2029.77 | 1735.39 | 2031.23 | 317.1 | 353.47 | 461.64 | 348.46 | 1030.44 | 874.69 | 788.43 | 666.13 | -78.67 | -1031.37 | -1061.38 | -1140.15 | -1304.01 | -264.73 | -219.74 | -165.63 | -151.39 | -143.18 | -166.46 | -138.65 | -125.74 | -117.82 | -83.6 | -46.02 | -35.7 | -12.73 | 5.02 | 3.82 | 6.3 | 5.07 | 5.48 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2148.21 | -1304.01 | 246.71 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 20.03 | 4.32 % | $ 581 M |  USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.41 | 2.88 % | $ 496 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 114.97 | 17.09 % | $ 14.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 115.09 | 1.36 % | $ 9.49 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.8 | - | $ 7.96 M | USA |
 |
Agilent Technologies
A
|
25.0 | $ 113.78 | 2.96 % | $ 34.6 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 141.92 | 0.17 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 140.34 | 7.16 % | $ 6.56 B | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 2.39 | 21.32 % | $ 3.18 M | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 21.15 | 3.02 % | $ 1.13 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 96.09 | 3.44 % | $ 6.49 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 421.87 | 0.47 % | $ 12.2 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 082.67 | 3.04 % | $ 22.3 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
National Research Corporation
NRC
|
161.47 | $ 19.26 | 2.72 % | $ 431 M | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Natera
NTRA
|
-76.66 | $ 204.92 | 4.53 % | $ 20.2 B | USA |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 7.95 | 12.93 % | $ 709 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 156.03 | 2.36 % | $ 7.73 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.9 | 6.08 % | $ 1.14 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 3.81 | 7.32 % | $ 353 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.74 | 2.65 % | $ 25.4 B |  Niderland |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 451.79 | 0.89 % | $ 170 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 5.71 | 3.07 % | $ 238 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 53.66 | 8.4 % | $ 3.21 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.35 | -1.26 % | $ 5.4 M | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.6 | 6.95 % | $ 216 M | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 257.42 | 1.47 % | $ 21.4 B | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 341.32 | 2.42 % | $ 20.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 8.83 | 5.75 % | $ 1.92 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 193.75 | 1.92 % | $ 21.5 B | USA |